Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
79.99
-1.38 (-1.70%)
Sep 1, 2026, 2:54 PM EDT - Market open
Globus Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,740 | 11,685 | 11,262 | 7,343 | 7,415 | 7,326 | |
Market Cap Growth | 29.78% | 3.76% | 53.38% | -0.97% | 1.22% | 13.84% |
Enterprise Value | 10,011 | 11,398 | 11,092 | 7,122 | 6,506 | 6,347 |
Last Close Price | 81.37 | 87.31 | 82.71 | 53.29 | 74.27 | 72.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.46 | 21.73 | 109.36 | 59.76 | 38.99 | 49.11 |
Forward PE | 15.67 | 21.59 | 25.54 | 20.76 | 32.74 | 33.48 |
PS Ratio | 3.42 | 3.98 | 4.47 | 4.68 | 7.25 | 7.65 |
PB Ratio | 2.29 | 2.56 | 2.70 | 1.84 | 4.02 | 4.21 |
P/TBV Ratio | 4.08 | 4.88 | 5.78 | 4.48 | 4.68 | 4.91 |
P/FCF Ratio | 14.24 | 19.85 | 27.79 | 44.44 | 71.01 | 33.40 |
P/OCF Ratio | 11.82 | 15.51 | 21.63 | 30.16 | 41.55 | 26.52 |
PEG Ratio | 1.28 | 1.51 | 1.82 | 1.81 | 2.71 | 3.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.19 | 3.88 | 4.40 | 4.54 | 6.36 | 6.62 |
EV/EBITDA Ratio | 9.93 | 13.00 | 15.97 | 17.00 | 21.30 | 23.97 |
EV/EBIT Ratio | 13.73 | 18.99 | 25.15 | 26.04 | 27.44 | 32.57 |
EV/FCF Ratio | 13.27 | 19.36 | 27.37 | 43.11 | 62.31 | 28.93 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.03 | 0.13 | 0.13 | 0.00 | - |
Debt / EBITDA Ratio | 0.11 | 0.13 | 0.75 | 1.19 | 0.02 | - |
Debt / FCF Ratio | 0.15 | 0.20 | 1.33 | 3.16 | 0.06 | - |
Net Debt / Equity Ratio | -0.15 | -0.11 | -0.10 | -0.02 | -0.51 | -0.58 |
Net Debt / EBITDA Ratio | -0.72 | -0.58 | -0.60 | -0.17 | -3.06 | -3.80 |
Net Debt / FCF Ratio | -0.96 | -0.87 | -1.03 | -0.44 | -8.96 | -4.58 |
Asset Turnover | 0.60 | 0.56 | 0.49 | 0.44 | 0.51 | 0.53 |
Inventory Turnover | 1.23 | 1.32 | 1.09 | 0.83 | 0.98 | 1.03 |
Quick Ratio | 2.78 | 2.61 | 1.72 | 2.61 | 4.17 | 4.35 |
Current Ratio | 4.62 | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 |
Return on Equity (ROE) | 11.81% | 12.29% | 2.52% | 4.21% | 10.60% | 9.19% |
Return on Assets (ROA) | 8.74% | 7.11% | 5.33% | 4.77% | 7.35% | 6.70% |
Return on Invested Capital (ROIC) | 13.93% | 13.41% | 9.61% | 7.51% | 13.72% | 13.53% |
Return on Capital Employed (ROCE) | 14.60% | 12.50% | 10.00% | 5.80% | 12.40% | 10.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.98% | 4.60% | 0.91% | 1.67% | 2.56% | 2.04% |
FCF Yield | 7.02% | 5.04% | 3.60% | 2.25% | 1.41% | 2.99% |
Buyback Yield / Dilution | 1.18% | 0.58% | -20.27% | -11.68% | 0.95% | -2.63% |